October 17, 2026 · Journal of pediatric orthopedics. Part B · DOI: 10.1097/BPB.0000000000001408

Beyond surgery: a scoping review of pharmaceutical approaches in treating congenital pseudarthrosis of the tibia.

Listen to this summary

This scoping review asks whether pharmacologic or biologic adjuncts (such as BMP-2, BMP-7/OP-1, bisphosphonates, and mesenchymal stromal cells) can improve bone union in congenital pseudarthrosis of the tibia, where surgical nonunion and refracture remain common. Across 13 studies (2006–2025, mostly small case series), contemporary BMP-2 cross-union protocols combined with bisphosphonates reported near-100% union within 3–9 months with fewer refractures, while earlier BMP-7 and single-agent results were more modest and variable. The authors conclude these promising structural outcomes are based on limited, non-comparative evidence and should be interpreted cautiously, with long-term safety and growth-plate effects still uncertain.

Arkesh Madegowda, Sitanshu Barik, Varun Garg, Anil Agarwal

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play